11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action

K Chapman, M Holmes, J Seckl - Physiological reviews, 2013 - journals.physiology.org
Glucocorticoid action on target tissues is determined by the density of “nuclear” receptors
and intracellular metabolism by the two isozymes of 11β-hydroxysteroid dehydrogenase …

Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism

EB Geer, J Islam, C Buettner - Endocrinology and Metabolism …, 2014 - endo.theclinics.com
Mechanisms of Glucocorticoid-Induced Insulin Resistance - Endocrinology and Metabolism
Clinics Skip to Main Content Skip to Main Menu Advertisement Endocrinology and …

Heterogeneity of white adipose tissue: molecular basis and clinical implications

KHM Kwok, KSL Lam, A Xu - Experimental & molecular medicine, 2016 - nature.com
Adipose tissue is a highly heterogeneous endocrine organ. The heterogeneity among
different anatomical depots stems from their intrinsic differences in cellular and physiological …

[HTML][HTML] Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity

MJ Lee, P Pramyothin, K Karastergiou… - Biochimica et Biophysica …, 2014 - Elsevier
Central obesity is associated with insulin resistance and dyslipidemia. Thus, the
mechanisms that control fat distribution and its impact on systemic metabolism have …

Glucocorticoids and cardiovascular disease

BR Walker - European journal of endocrinology, 2007 - academic.oup.com
Chronic excessive activation of glucocorticoid receptors induces obesity, insulin resistance,
glucose intolerance, dyslipidaemia and hypertension. Subtle abnormalities of the …

Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose …

VP Houde, S Bruˆlé, WT Festuccia, PG Blanchard… - Diabetes, 2010 - Am Diabetes Assoc
OBJECTIVE The mammalian target of rapamycin (mTOR)/p70 S6 kinase 1 (S6K1) pathway
is a critical signaling component in the development of obesity-linked insulin resistance and …

Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome

DP Macfarlane, S Forbes… - Journal of …, 2008 - joe.bioscientifica.com
Estrogen affects proliferation and migration of different skin components, thus influencing
wound healing processes. The human keratinocyte cell line NCTC 2544 has been used to …

The many faces of the adamantyl group in drug design

J Liu, D Obando, V Liao, T Lifa, R Codd - European journal of medicinal …, 2011 - Elsevier
Adamantyl-based compounds are used clinically for the treatment of neurological
conditions, as anti-viral agents and as agents against type 2 diabetes. The value of the …

The 11-β-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin …

J Rosenstock, S Banarer, VA Fonseca… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE 11-β-hydroxysteroid dehydrogenase type 1 (11βHSD1) converts inactive
cortisone into active cortisol, thereby amplifying intracellular glucocorticoid action. The …

[图书][B] Handbook of Obesity--Volume 1: Epidemiology, Etiology, and Physiopathology

GA Bray - 2014 - books.google.com
In recent years, we've developed a much better grasp of the biological and other factors
associated with the development of obesity. Reflecting our evolving understanding of …